Critical review of current left ventricular assist devices

Perfusion

Volumn 15, Issue 5, 2000, Pages 399-420

  Mahmood, A K ^a,b   Courtney, J M ^a   Westaby, S ^c   Akdis, M ^b   Reul, H ^b  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ARTICLE; ASSISTED CIRCULATION; BIOMEDICAL TECHNOLOGY ASSESSMENT; BLOOD FLOW; BLOOD PUMP; COST BENEFIT ANALYSIS; COW; DEVICE; HEALTH CARE COST; HEART FAILURE; HUMAN; MALE; MEDICAL TECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; PULSATILE FLOW; SHEEP;

EQUIPMENT DESIGN; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HUMANS; PULSATILE FLOW; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0033835437     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765910001500502     Document Type: Article

References (86)

1. Long-term implantable circulatory support
2. Implantable left ventricular assist devices: An evolving long-term cardiac replacement therapy
3. The need for artificial hearts
4. Bridging for heart transplantation by different types of ventricular assist device
5. Clinical experience with the Novacor ventricular assist system: Bridge to transplantation and the transition to permanent application
6. The Heart-Mate left ventricular assist system overview and 12-year experience
7. Cardiac devices
8. Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device
9. The cool seal system: A practical solution to the shaft seal problem and heat related complications with implantable rotary blood pumps
10. The analysis, design, and testing of a blood lubricated hydrodynamic journal bearing
11. The Debakey/NASA axial flow ventricular assist device
12. First bridge to cardiac transplantation with the Debakey VAD axial flow pump
13. In vivo development tests of an axial flow pump based LVAS
14. New technologies in the treatment of severe cardiac failure: The Texas heart institute experience
15. Alumina ceramic and polyethylene: Materials for double pivot bearing system of an implantable centrifugal ventricular assist device
16. Study of secondary flow in centrifugal blood pumps using a flow visualization method with a high-speed video camera
17. Hemolytic effect of surface roughness of an impeller in a centrifugal blood pump
18. Development and initial testing of a pediatric centrifugal blood pump
19. Bio-Medicus centrifugal ventricular support for postcardiotomy cardiac failure: A review of 129 cases
20. Comparison of the Gyro C1E3 and BioMedicus centrifugal pump performances during cardiopulmonary bypass
21. Magnetically suspended centrifugal pump as an implantable ventricular assist system
22. More than 1 year continuous operation of a centrifugal pump with a magnetically suspended impeller
23. Cora valveless pulsatile rotary pump: New design and control
24. Cleveland clinic roto-dynamic pump
25. Circulatory support with pneumatic paracorporeal ventricular assist device in infants and children
26. Neonatal mechanical bridging to total orthotopic heart transplantation
27. Ventricular assist systems: Experience in Japan with Toyobo pump and Zeon pump
28. Use of the Nippon-Zeon pneumatic ventricular assist device as a bridge to cardiac transplantation
29. Pierce-Donachy pediatric VAD: Progress in development
30. ABIOMED BVS 5000: Experience and potential advantages
31. Mechanical circulatory support: The Bad Oeynhausen experience
32. Experience with right ventricular assist devices for perioperative right-sided circulatory failure
33. Mechanical circulatory support with the Thoratec assisted device in patients with postcardiotomy cardiogenic shock
34. Importance of preoperative liver function as a predictor of survival in patients supported with Thoratec ventricular assist devices as a bridge to transplantation
35. Portable pneumatic biventricular driver for the Thoratec ventricular assist device
36. Evaluation of a transaortic pulsatile left ventricular assist device (Heart Ranger)
37. The HeartMate left ventricular assist system: Worldwide clinical results
38. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system
39. Ventricular assist systems: Clinical application
40. The HeartMate left ventricular assist system: Looking into the future
41. Evolution of battery-powered, vented left ventricular assist devices
42. Implantable LVAD infections: Implications for permanent use of the device
43. Weaning from mechanical cardiac support in patients with idioathic dilated cardiomyopathy
44. Improved left ventricular function after chronic left ventricular unloading
45. Hemodynamic and physiologic changes during support with an implantable left ventricular assist device
46. Wearable long-term mechanical support for patients with end-stage heart disease: A tenable goal
47. The Linkoping-Lund surgical experience with the HeartMate left ventricular assist system
48. Internal pulsatile circulatory support
49. Chronic left ventricular support with a vented electric assist device
50. Ultracompact, completely implantable permanent use electromechanical ventricular assist device and total artificial heart
51. Inflow conduit in implantable left ventricular assist device (LVAD): Influence on outcomes
52. Application of wearable Novacor left ventricular assist system for patients with end-stage cardiomyopathy: Osaka experience
53. The Novacor left ventricular assist system: Lessons learned
54. Cerebral and systemic embolization during left ventricular support with the Novacor N100 device
55. Evolution of pseudoneointimal growth in LVAS graft conduits
56. Experience with univentricular support in mortally ill cardiac transplant candidates
57. Right ventricular infarction during left ventricular assist system support
58. Discharging patients who are undergoing mechanical circulatory support
59. First experience of Novacor implant at the Heart Institute of Japan
60. Clinical implantation of the wearable Baxter Novacor ventricular assist system
61. Extended support with permanent systems: Percutaneous versus totally implantable
62. A small pulsatile blood pump for ventricular support during end-stage heart failure
63. Remote monitoring and control of artificial hearts and assist devices
64. Progress with the HeartSaver ventricular assist device
65. LVAD power delivery: A percutaneous approach to avoid infection
66. Fine trabecularized carbon: Ideal material and texture for percutaneous device system of permanent left ventricular assist device
67. An implantable centrifugal pump using transcutaneous magnet coupling between pump head and motor unit
68. Clinical evaluation of pulsatile flow mode of Terumo Capiox centrifugal pump
69. A new index for characterizing pulsatility: Recovery of renal function
70. Can we develop a nonpulsatile permanent rotary blood pump? Yes, we can
71. In vivo and in vitro evaluation of the pulsatile mode of a magnetically suspended centrifugal pump
72. HeartMate implantable left ventricular assist device: Bridge to transplantation and future applications
73. Emergency versus elective/urgent left ventricular assist device implantation
74. Mechanical bridge to transplantation: When is too early? When is too late?
75. Development of a totally implantable intrathoracic ventricular assist device
76. Development of design methods of a centrifugal blood pump with in vitro tests, flow visualization, and computational fluid dynamics: Results in hemolysis tests
77. Hemolytic effect of the secondary vane incorporated into the backside of the impeller
78. Quantitative visualization of flow through a centrifugal blood pump: Effect of washout holes
79. Washout hole flow measurement for the development of a centrifugal blood pump
80. Experience with generally accepted centrifugal pumps: Personal and collective experience
81. Physiology of univentricular versus biventricular support
82. MEDOS HIA-VAD biventricular assist device for bridge to recovery in fulminant myocarditis
83. Insights into thromboembolism and bleeding
84. Results of extended bridge to transplantation: Window into the future of permanent ventricular assist devices
85. In vitro characterisation and comparison of ventricular assist devices
86. What will happen to permanent left ventricular assist device recipients? Clues from long-term outcomes of heterotopic heart transplants